化学疗法耐药恶性癌细胞细胞细胞下细胞物理性质变化的特征
Dong Wang1,2, I Wayan Ardyan Sudharta Putra1, Hiroko Oshima1
1Division of Genetics Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.
Analytical chemistry
|May 29, 2025
概括
扫描离子导电显微镜揭示了耐药结直肠癌细胞的物理差异. 这种技术可以帮助识别针对性癌症治疗的生物标志物,解决化疗药物耐药性挑战.
科学领域:
- 生物物理学的生物物理.
- 细胞生物学 细胞生物学
- 纳米技术纳米技术
背景情况:
- 扫描离子导电显微镜 (SICM) 是一种非接触式纳米探针工具,用于分析软生物样本,特别是活细胞.
- 细胞表面的物理性质,如刚性,可以作为无标签的生物标志物来区分瘤和正常细胞,加剧了对癌症研究的兴趣.
- 物理因素 (如矩阵刚性和压力) 在促进瘤耐药性的作用越来越被认可,但针对向治疗的耐药细胞的量化尚未得到充分研究.
研究的目的:
- 为了研究耐药结直肠癌细胞系的亚细胞物理性质 (高度,粗度,度).
- 探索SICM在理解和潜在地克服化疗药物耐药性的潜力.
- 为了将耐药细胞的物理性质变化与针对性癌症治疗的含义相关联.
主要方法:
- 使用5-甲 (5-FU) 和氧沙 (OXA) 建立了三个耐药的人类结直肠癌细胞系 (DLD1,SW620,HT29).
- 使用高速SICM可视化和量化对照细胞和耐药细胞系的表面物理特性.
- 进行统计分析,以比较对照样本和耐药样本之间的物理性质变化.
主要成果:
- 与对照样本相比,在耐药细胞系中鉴定了亚细胞物理性质的明显变化,包括硬度.
- 观察到细胞同时抵抗5-FU和OXA时,硬度的变化减少.
- 证明了SICM在癌细胞中在亚细胞水平上可视化和量化物理差异的能力.
结论:
- 耐药癌细胞系的亚细胞物理性质不同于它们的敏感对应物.
- SICM 是一种有价值的工具,用于描述耐药细胞的物理属性,为向治疗策略提供了洞察力.
- 这项研究突出了SICM在帮助开发向疗法的潜力,以克服癌症治疗中的化疗药物耐药性.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


